UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 10 | October 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 10 Issue 4
April-2023
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2304F24


Registration ID:
546783

Page Number

n168-n179

Share This Article


Jetir RMS

Title

Applying Principal Component Analysis to Large Pharmaceutical Datasets

Abstract

In the rapidly evolving field of pharmaceutical research, data analysis has become a cornerstone of innovation and efficiency. The abundance of large-scale datasets generated by modern pharmaceutical processes presents both opportunities and challenges. Principal Component Analysis (PCA) offers a robust method for reducing dimensionality, enhancing interpretability, and preserving significant information within these extensive datasets. This paper explores the application of PCA to large pharmaceutical datasets, highlighting its utility in simplifying complex data structures and facilitating meaningful insights. By examining case studies across various stages of drug discovery, development, and clinical trials, the paper demonstrates how PCA can streamline data analysis, improve decision-making, and support the identification of key variables. We discuss the implementation process, potential pitfalls, and best practices for leveraging PCA in pharmaceutical research. Furthermore, the paper addresses the integration of PCA with other advanced analytical techniques to enhance data-driven strategies in drug development. The findings underscore the transformative potential of PCA in managing and interpreting large pharmaceutical datasets, ultimately contributing to more efficient and targeted drug development processes.

Key Words

Principal Component Analysis, Pharmaceutical Datasets, Data Dimensionality Reduction, Drug Development, Data Interpretation, Machine Learning, Bioinformatics, Clinical Trials, Data Visualization, Multivariate Analysis

Cite This Article

"Applying Principal Component Analysis to Large Pharmaceutical Datasets", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.10, Issue 4, page no.n168-n179, April-2023, Available :http://www.jetir.org/papers/JETIR2304F24.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Applying Principal Component Analysis to Large Pharmaceutical Datasets", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.10, Issue 4, page no. ppn168-n179, April-2023, Available at : http://www.jetir.org/papers/JETIR2304F24.pdf

Publication Details

Published Paper ID: JETIR2304F24
Registration ID: 546783
Published In: Volume 10 | Issue 4 | Year April-2023
DOI (Digital Object Identifier):
Page No: n168-n179
Country: -, -, India .
Area: Engineering
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

00029

Print This Page

Current Call For Paper

Jetir RMS